Disease modifying therapies raise risk of precancerous growths in over 45s Published: 10 November 2020 The use of certain disease-modifying therapies (DMTs) in people with multiple sclerosis (MS) increases the risk of precancerous growths in those over 45, a new scientific analysis has found.  The researchers however failed to find